Graf Akcie CBPO (China Biologic Products Holdings Inc). Diskuze k akciím CBPO. Aktuální informace CBPO.

Základní informace o společnosti China Biologic Products Holdings Inc (Akcie CBPO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 4.65B
Hodnota podniku (EV) N/A
Tržby 514.397M
EBITDA 206.042M
Zisk 152.285M
Růst v tržbách Q/Q 1.78 %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) 42.16
Forward P/E N/A
EV/Sales 6.60
EV/EBITDA N/A
EV/EBIT 18.10
PEG 2.58
Price/Sales 8.88
P/FCF 19.77
Price/Book 2.35
Účetní hodnota na akcii 73.46
Hotovost na akcii 44.20
FCF vůči ceně 5.15 %
Počet zaměstnanců 0
Tržba na zaměstnance N/A
Profit margin 29.04 %
Operating margin 37.26 %
Gross margin 65.68 %
EBIT margin 37.26 %
EBITDA margin 40.06 %
EPS - Zisk na akcii 4.09
EPS - Kvartální růst 71.70 %
EPS - Očekávaný růst příští rok -13.46 %
Return on assets 7.24 %
Return on equity 8.25 %
ROIC 8.10 %
ROCE 8.98 %
Dluhy/Equity 0.09
Čistý dluh/EBITDA N/A
Current ratio 11.77
Quick Ratio 9.89
Volatilita 0.72
Beta 0.00
RSI 97.83
Cílová cena analytiků 102
Známka akcie (dle analytiků) 3.00
Insider ownership 45.08 %
Institutional ownership 51.03 %
Počet akcií 39.362M
Procento shortovaných akcií 3.45 %
Short ratio 7.23 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2009
Země China

Finanční výsledky akcie CBPO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$503.745$466.878$370.407$341.169$296.458$243.252
Cost Of Goods Sold$174.667$146.787$125.517$124.034$106.483$80.025
Gross Profit$329.078$320.09$244.89$217.135$189.975$163.226
Research And Development Expenses$11.735$9.524$6.504$7.022$6.024$4.162
SG&A Expenses$153.696$164.393$102.528$66.198$51.365$42.837
Other Operating Income Or Expenses-----$-5.068
Operating Expenses$340.097$320.705$234.548$197.255$163.872$132.093
Operating Income$163.648$146.173$135.859$143.915$132.586$111.159
Total Non-Operating Income/Expense$27.846$19.831$10.549$10.005$2.513$11.593
Pre-Tax Income$191.494$166.003$146.408$153.919$135.098$122.752
Income Taxes$28.099$18.036$64.172$25.126$20.993$26.64
Income After Taxes$163.395$147.967$82.236$128.793$114.106$96.113
Other Income------
Income From Continuous Operations$163.395$147.967$82.236$128.793$114.106$96.113
Income From Discontinued Operations------
Net Income$137.117$124.984$65.754$101.792$86.972$70.917
EBITDA$189.889$169.398$148.767$156.653$141.62$118.906
EBIT$163.648$146.173$135.859$143.915$132.586$111.159
Basic Shares Outstanding393527272624
Shares Outstanding393528272726
Basic EPS$3.55$3.54$2.40$3.79$3.40$2.85
EPS - Earnings Per Share$3.53$3.53$2.38$3.74$3.27$2.71
# 2020 2019 2018 2017 2016 2015
Current Ratio10.893811.09286.07495.30255.15122.32
Long-term Debt / Capital-----0.1269
Debt/Equity Ratio-----0.3557
Gross Margin65.326468.559866.113763.644364.081767.1018
Operating Margin32.486331.308636.678242.182744.723445.6971
EBIT Margin32.486331.308636.678242.182744.723445.6971
EBITDA Margin37.695436.283240.163245.916447.770648.882
Pre-Tax Profit Margin38.01435.556139.526245.115245.570950.463
Net Profit Margin27.219626.770217.751929.836229.33729.1537
Asset Turnover0.25990.23230.45780.5640.53760.5444
Inventory Turnover Ratio0.69660.60330.59890.7930.84250.7899
Receiveable Turnover5.02393.73164.793810.058411.7912.5369
Days Sales In Receivables72.653397.814376.139436.28830.958629.114
ROE - Return On Equity9.20618.021212.378924.713924.435734.9168
Return On Tangible Equity11.722910.235312.870825.875325.735136.4958
ROA - Return On Assets8.43177.361610.164421.289720.691321.5091
ROI - Return On Investment9.20618.021212.378924.713924.435730.4866
Book Value Per Share46.14846.865124.059319.178517.568211.0966
Operating Cash Flow Per Share2.9625-0.768-0.82190.40590.47670.9459
Free Cash Flow Per Share3.3478-0.3042-0.38070.0374-0.29141.0213